• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mTOR 在脂质生物合成中的新作用。

An emerging role of mTOR in lipid biosynthesis.

机构信息

Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142, USA.

出版信息

Curr Biol. 2009 Dec 1;19(22):R1046-52. doi: 10.1016/j.cub.2009.09.058.

DOI:10.1016/j.cub.2009.09.058
PMID:19948145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3390254/
Abstract

Lipid biosynthesis is essential for the maintenance of cellular homeostasis. The lipids produced by cells (glycerolipids, fatty acids, phospholipids, cholesterol, and sphingolipids) are used as an energy source/reserve, as building blocks for membrane biosynthesis, as precursor molecules for the synthesis of various cellular products, and as signaling molecules. Defects in lipid synthesis or processing contribute to the development of many diseases, including obesity, insulin resistance, type 2 diabetes, non-alcoholic fatty liver disease, and cancer. Studies published over the last few years have shown that the target of rapamycin (TOR), a conserved serine/threonine kinase with an important role in regulating cell growth, controls lipid biosynthesis through various mechanisms. Here, we review these findings and briefly discuss their potential relevance for human health and disease.

摘要

脂质生物合成对于维持细胞内环境稳定至关重要。细胞产生的脂质(甘油磷脂、脂肪酸、磷脂、胆固醇和鞘脂)可用作能量源/储备、膜生物合成的构建模块、各种细胞产物合成的前体分子以及信号分子。脂质合成或加工的缺陷会导致多种疾病的发生,包括肥胖症、胰岛素抵抗、2 型糖尿病、非酒精性脂肪肝和癌症。过去几年发表的研究表明,雷帕霉素靶蛋白(TOR)是一种保守的丝氨酸/苏氨酸激酶,在调节细胞生长方面具有重要作用,它通过多种机制控制脂质生物合成。在这里,我们回顾了这些发现,并简要讨论了它们对人类健康和疾病的潜在相关性。

相似文献

1
An emerging role of mTOR in lipid biosynthesis.mTOR 在脂质生物合成中的新作用。
Curr Biol. 2009 Dec 1;19(22):R1046-52. doi: 10.1016/j.cub.2009.09.058.
2
Akt Serine/Threonine Kinase 1 Regulates de Novo Fatty Acid Synthesis through the Mammalian Target of Rapamycin/Sterol Regulatory Element Binding Protein 1 Axis in Dairy Goat Mammary Epithelial Cells.Akt丝氨酸/苏氨酸激酶1通过雷帕霉素哺乳动物靶点/固醇调节元件结合蛋白1轴调控奶山羊乳腺上皮细胞中的从头脂肪酸合成
J Agric Food Chem. 2018 Feb 7;66(5):1197-1205. doi: 10.1021/acs.jafc.7b05305. Epub 2018 Jan 25.
3
mTOR's role in ageing: protein synthesis or autophagy?雷帕霉素靶蛋白(mTOR)在衰老中的作用:蛋白质合成还是自噬?
Aging (Albany NY). 2009 Jul 20;1(7):586-97. doi: 10.18632/aging.100070.
4
Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony.哺乳动物雷帕霉素靶蛋白(mTOR):指挥细胞信号交响乐。
J Biol Chem. 2010 May 7;285(19):14071-7. doi: 10.1074/jbc.R109.094003. Epub 2010 Mar 15.
5
mTOR signaling in cancer cell motility and tumor metastasis.癌细胞迁移和肿瘤转移中的mTOR信号传导
Crit Rev Eukaryot Gene Expr. 2010;20(1):1-16. doi: 10.1615/critreveukargeneexpr.v20.i1.10.
6
Steatosis and insulin resistance in hepatitis C: a way out for the virus?丙型肝炎中的脂肪变性和胰岛素抵抗:病毒的出路?
World J Gastroenterol. 2009 Oct 28;15(40):5014-9. doi: 10.3748/wjg.15.5014.
7
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice.哺乳动物雷帕霉素靶蛋白调控多囊蛋白-2缺陷型小鼠血管内皮生长因子依赖性肝囊肿生长。
Hepatology. 2010 May;51(5):1778-88. doi: 10.1002/hep.23511.
8
[Lipin 1 in lipid metabolism].[脂联素1在脂质代谢中的作用]
Yakugaku Zasshi. 2011;131(8):1189-94. doi: 10.1248/yakushi.131.1189.
9
Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism.脂肪细胞特异性敲除小鼠中的rictor 会损害胰岛素调节的脂肪细胞和全身葡萄糖及脂质代谢。
Diabetes. 2010 Jun;59(6):1397-406. doi: 10.2337/db09-1061. Epub 2010 Mar 23.
10
Integration of general amino acid control and target of rapamycin (TOR) regulatory pathways in nitrogen assimilation in yeast.酵母氮同化过程中通用氨基酸控制和雷帕霉素靶蛋白(TOR)调节途径的整合。
J Biol Chem. 2010 May 28;285(22):16893-911. doi: 10.1074/jbc.M110.121947. Epub 2010 Mar 16.

引用本文的文献

1
Transcriptomic and Proteomic Insights Into Buffalo Milk Fat Synthesis and the Role of IGFBP4 in BMECs.水牛乳脂肪合成的转录组学和蛋白质组学见解以及IGFBP4在水牛乳腺上皮细胞中的作用
FASEB J. 2025 Aug 31;39(16):e70971. doi: 10.1096/fj.202502191R.
2
Role of obesity and estrogen deficiency in non‑alcoholic fatty liver disease: Insights from a mouse model.肥胖和雌激素缺乏在非酒精性脂肪性肝病中的作用:来自小鼠模型的见解
Mol Med Rep. 2025 Oct;32(4). doi: 10.3892/mmr.2025.13629. Epub 2025 Jul 25.
3
SPNS1 variants cause multiorgan disease and implicate lysophospholipid transport as critical for mTOR-regulated lipid homeostasis.SPNS1基因变异导致多器官疾病,并表明溶血磷脂转运对mTOR调节的脂质稳态至关重要。
J Clin Invest. 2025 Jul 3;135(17). doi: 10.1172/JCI193099. eCollection 2025 Sep 2.
4
Blood metabolites as mediators in erectile dysfunction: insights from a multi-center proteomics and genetic study.血液代谢物作为勃起功能障碍的介质:来自多中心蛋白质组学和遗传学研究的见解
Front Pharmacol. 2025 Jun 2;16:1568780. doi: 10.3389/fphar.2025.1568780. eCollection 2025.
5
Volatilomic response to targeted cancer therapy in vitro.体外对靶向癌症治疗的挥发物组反应
Sci Rep. 2025 Jun 3;15(1):19445. doi: 10.1038/s41598-025-04886-5.
6
Constitutively active mTORC1 signaling modifies the skeletal muscle metabolome and lipidome response to exercise.组成型激活的mTORC1信号传导可改变骨骼肌代谢组和脂质组对运动的反应。
J Appl Physiol (1985). 2025 May 1;138(5):1173-1186. doi: 10.1152/japplphysiol.00987.2024. Epub 2025 Apr 11.
7
Drug-Based Lifespan Extension in Mice Strongly Affects Lipids Across Six Organs.基于药物的小鼠寿命延长对六个器官的脂质有强烈影响。
Aging Cell. 2025 May;24(5):e14465. doi: 10.1111/acel.14465. Epub 2025 Mar 24.
8
Chchd10: A Novel Metabolic Sensor Modulating Adipose Tissue Homeostasis.Chchd10:一种调节脂肪组织稳态的新型代谢传感器。
Adv Sci (Weinh). 2025 Apr;12(15):e2408763. doi: 10.1002/advs.202408763. Epub 2025 Feb 22.
9
Improvements in Exercise for Alzheimer's Disease: Highlighting FGF21-Induced Cerebrovascular Protection.阿尔茨海默病运动疗法的进展:聚焦成纤维细胞生长因子21诱导的脑血管保护作用
Neurochem Res. 2025 Feb 4;50(2):95. doi: 10.1007/s11064-025-04350-w.
10
Dietary Restriction and Lipid Metabolism: Unveiling Pathways to Extended Healthspan.饮食限制与脂质代谢:揭示延长健康寿命的途径
Nutrients. 2024 Dec 23;16(24):4424. doi: 10.3390/nu16244424.

本文引用的文献

1
Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway.胰岛素通过Akt-TSC2-mTORC1信号通路刺激脂肪生成。
PLoS One. 2009 Jul 10;4(7):e6189. doi: 10.1371/journal.pone.0006189.
2
mTOR complex 2 in adipose tissue negatively controls whole-body growth.脂肪组织中的mTOR复合物2对全身生长起负向调控作用。
Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9902-7. doi: 10.1073/pnas.0811321106. Epub 2009 Jun 3.
3
Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).库-0063794是雷帕霉素哺乳动物靶点(mTOR)的特异性抑制剂。
Biochem J. 2009 Jun 12;421(1):29-42. doi: 10.1042/BJ20090489.
4
New insights into mTOR signaling: mTORC2 and beyond.对mTOR信号传导的新见解:mTORC2及其他。
Sci Signal. 2009 Apr 21;2(67):pe27. doi: 10.1126/scisignal.267pe27.
5
Rictor/TORC2 regulates Caenorhabditis elegans fat storage, body size, and development through sgk-1.Rictor/TORC2通过sgk-1调控秀丽隐杆线虫的脂肪储存、体型和发育。
PLoS Biol. 2009 Mar 3;7(3):e60. doi: 10.1371/journal.pbio.1000060.
6
Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans.Rictor/TORC2调节秀丽隐杆线虫的脂肪代谢、进食、生长和寿命。
Genes Dev. 2009 Feb 15;23(4):496-511. doi: 10.1101/gad.1775409.
7
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.mTOR的活性位点抑制剂靶向mTORC1和mTORC2的雷帕霉素抗性输出。
PLoS Biol. 2009 Feb 10;7(2):e38. doi: 10.1371/journal.pbio.1000038.
8
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.一种ATP竞争性的雷帕霉素哺乳动物靶点抑制剂揭示了mTORC1的雷帕霉素抗性功能。
J Biol Chem. 2009 Mar 20;284(12):8023-32. doi: 10.1074/jbc.M900301200. Epub 2009 Jan 15.
9
A new player in the orchestra of cell growth: SREBP activity is regulated by mTORC1 and contributes to the regulation of cell and organ size.细胞生长交响乐中的新成员:固醇调节元件结合蛋白(SREBP)活性受雷帕霉素靶蛋白复合体1(mTORC1)调控,并参与细胞和器官大小的调节。
Biochem Soc Trans. 2009 Feb;37(Pt 1):278-83. doi: 10.1042/BST0370278.
10
Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration.雷帕霉素靶蛋白(Raptor)在脂肪组织中的特异性敲除导致小鼠变瘦,线粒体呼吸增强。
Cell Metab. 2008 Nov;8(5):399-410. doi: 10.1016/j.cmet.2008.09.003.